IQVIA Holdings Inc. (NYSE:IQV)’s earnings report is awaited by WallStreet on May, 1, as reported by Faxor. Last year’s EPS was $1.24, while now analysts expect change of 13.71 % up from current $1.41 EPS. If reported the P/E will be 25.27 with $277.20 million profit. 2.92 % EPS growth is what analysts predict. $1.37 EPS was revealed for previous quarter. The stock decreased 0.46% or $0.66 during the last trading session, hitting $142.52.Currently IQVIA Holdings Inc. is uptrending after 45.57% change in last April 14, 2018. IQV has also 725,124 shares volume. IQV outperformed by 41.20% the S&P500.

IQVIA Holdings Inc. (NYSE:IQV) Ratings Coverage

In total 3 analysts cover IQVIA Holdings (NYSE:IQV). “Buy” rating has 3, “Sell” are 0, while 0 are “Hold”. (NYSE:IQV) has 100% bullish analysts. 3 are the (NYSE:IQV)’s ratings reports on Apr 14, 2019 according to StockzIntelligence Inc. On Monday, February 25 the stock has “Buy” rating by Argus Research. The company rating was maintained by Barclays Capital on Monday, March 18. In Tuesday, February 19 report Wells Fargo maintained it with “Outperform” rating and $160 target.

IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific.The company has $28.02 billion market cap. It operates through three divisions: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.114.94 is the P/E ratio. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations.

For more IQVIA Holdings Inc. (NYSE:IQV) news announced briefly go to: Seekingalpha.com, Gurufocus.com, Businesswire.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Bigger Is Not Always Better – Seeking Alpha” announced on May 22, 2018, “Larry Robbins Powers Into Lithium Producer Livent – GuruFocus.com” on March 15, 2019, “IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry – Business Wire” with a publish date: February 04, 2019, “IQVIA prices equity offering at $141 – Seeking Alpha” and the last “Iqvia launches equity offering – Seeking Alpha” with publication date: March 05, 2019.